| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/03/2010 | US20100137217 Fibrosis inhibitor for implanted organ |
| 06/03/2010 | US20100137208 Intratumorally administered lactoferrin in the treatment of malignantneoplasms and other hyperproliferative diseases |
| 06/03/2010 | US20100137203 Method for preparing a cell-derived extracellular matrix membrane |
| 06/03/2010 | US20100136695 Double-stranded oligonucleotides |
| 06/03/2010 | US20100136693 Mutants of Deoxycytidine Kinase Having Extended Enzymatic Activity |
| 06/03/2010 | US20100136623 Mutations in ion channels |
| 06/03/2010 | US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 06/03/2010 | US20100136130 Preparation for the Controlled Release of Bioactive Natural Substances |
| 06/03/2010 | US20100136114 De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progentitor cells |
| 06/03/2010 | US20100136113 Phytases, nucleic acids encoding them and methods for making and using them |
| 06/03/2010 | US20100136107 Liquid Therapeutic Composition |
| 06/03/2010 | US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo |
| 06/03/2010 | US20100136084 Responsive polymeric system |
| 06/03/2010 | US20100136083 Metal Implants |
| 06/03/2010 | US20100136063 Immunotherapy for Treatment of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid Peptides |
| 06/03/2010 | US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response |
| 06/03/2010 | US20100136012 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 06/03/2010 | US20100135992 Prolongation of Survival of an Allograft by Inhibiting Complement Activity |
| 06/03/2010 | US20100135988 Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or alpha1 type IV collagen |
| 06/03/2010 | US20100135987 Isolation and purification of antibodies using protein a affinity chromatography |
| 06/03/2010 | US20100135968 Oligodendrocyte Production From Multipotent Neural Stem Cells |
| 06/03/2010 | US20100135957 Chimeric Heteromultimer Adhesins |
| 06/03/2010 | US20100135927 Mild Oral Care Compositions |
| 06/03/2010 | US20100135909 Dendrimers and methods of making and using thereof |
| 06/03/2010 | US20100135907 Oral Drug Compliance Monitoring Using Sound Detection |
| 06/03/2010 | CA2745004A1 Pyridine-3-carboxyamide derivative |
| 06/03/2010 | CA2744289A1 Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same |
| 06/03/2010 | CA2743722A1 Hsp90 inhibitors for therapeutic treatment |
| 06/02/2010 | EP2192190A1 Yogurt containing pectin hydrolysis products |
| 06/02/2010 | EP2192179A1 Cdh3 peptide and medicinal agent comprising the same |
| 06/02/2010 | EP2192131A1 Immunoglobulins devoid of light chains |
| 06/02/2010 | EP2192130A1 Human DR4 antibodies and uses thereof |
| 06/02/2010 | EP2192116A1 Indazole acrylic acid amide compound |
| 06/02/2010 | EP2192109A1 Bicyclic -amino acid derivative |
| 06/02/2010 | EP2192108A1 Novel dihydronaphthalene compound and use thereof |
| 06/02/2010 | EP2191849A1 Drug for suppressing pathogen occurring<i>in vivo</i> |
| 06/02/2010 | EP2191836A1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 06/02/2010 | EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone |
| 06/02/2010 | EP2191830A1 Solid preparation comprising npyy5 receptor antagonist |
| 06/02/2010 | EP2190455A1 Agents with angiogenic and wound healing activity |
| 06/02/2010 | EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent |
| 06/02/2010 | EP1541553B1 Indoline compound and medicinal use thereof |
| 06/02/2010 | EP1534736B1 Nogo receptor antagonists |
| 06/02/2010 | EP1483228B1 Nk1 antagonists |
| 06/02/2010 | EP1481000B1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 06/02/2010 | EP1425016B1 Compositions and methods of treatment of cancer |
| 06/02/2010 | EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance |
| 06/02/2010 | EP1066050B2 Application of hsp70 proteins |
| 06/02/2010 | DE69224660C5 Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen Means for modulating process by retinoid receptors and for useful links |
| 06/02/2010 | CN1915049B Pumpkin green tea beverage and preparation method |
| 06/02/2010 | CN1915048B Pumpkin milk tea and preparation method |
| 06/02/2010 | CN1659180B Novel recombinant anticoagulant proteins |
| 06/02/2010 | CN1291231B Human telomerase catalytic subunit |
| 06/02/2010 | CN101720222A Drug having effect of promoting hepatocyte growth |
| 06/02/2010 | CN101480408B Nutrient health-care liquid for coloclysis |
| 06/02/2010 | CN101229217B Channels and collaterals uncloging acupuncture medicine |
| 06/02/2010 | CN101181578B Rose strip containing natural aromatic plant |
| 06/02/2010 | CN101181577B Lavender strip containing natural aromatic plant |
| 06/02/2010 | CN101181574B Chinese vetch strip containing natural aromatic plant |
| 06/02/2010 | CN101040914B Chinese traditional medicine compound for treating insafficiencg of kidney-yang and hypogastric blood stasis and its preparation method |
| 06/01/2010 | US7728133 Stable pharmaceutical compositions |
| 06/01/2010 | US7728025 Glucokinase activators as antidiabetic, antiobesity agents; 5-(4-methanesulfonyl-phenoxy)-2-pyrazin-2-yl-6-(2-carbamoyl-phenoxy)-1H-benzimidazole for example |
| 06/01/2010 | US7728010 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase |
| 06/01/2010 | US7728007 Therapeutic amides |
| 06/01/2010 | US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity |
| 06/01/2010 | US7727999 substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds, used as selective serotonin receptor antagonists, used rfor the treatment of schizophrenia, psychosis, headaches, hypertension, thrombosis, vasospasm, depression, anxiety, sleep disorders and appetite disorders |
| 06/01/2010 | US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 06/01/2010 | US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 06/01/2010 | US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections |
| 06/01/2010 | US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism |
| 06/01/2010 | US7727952 Methods for treating spinal and bulbar muscular atrophy using LHRH analogs |
| 06/01/2010 | US7727712 Having an immunostimulatory sequence comprising the sequence 5'-C, G-3', wherein an HBV antigen is not administered in conjunction with administration of said nucleotide; for treatment of subject with hepatitis B virus |
| 06/01/2010 | US7727536 EG-VEGF nucleic acids and polypeptides and methods of use |
| 06/01/2010 | US7727534 Gentically engineered viral particles for use in targeted tumor destruction; Antitumor agents |
| 06/01/2010 | US7727519 Method for treating hepatitis C virus with omega interferon |
| 06/01/2010 | CA2515841C Novel 2-pyridine carboxamide derivatives |
| 06/01/2010 | CA2490120C Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 06/01/2010 | CA2457965C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 06/01/2010 | CA2448737C Viral polymerase inhibitors |
| 06/01/2010 | CA2443456C Novel atisane compounds and use thereof |
| 06/01/2010 | CA2427030C Fatigue recovering or fatigue preventive agent for central nervous system and food for fatigue recovery or fatigue prevention |
| 06/01/2010 | CA2426625C Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 06/01/2010 | CA2423007C Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients |
| 06/01/2010 | CA2420055C Fibrinogen-lowering agent |
| 06/01/2010 | CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors |
| 06/01/2010 | CA2400626C Estrogen receptor modulators |
| 06/01/2010 | CA2332627C Porcine circovirus and parvovirus vaccine |
| 06/01/2010 | CA2288373C Human cerberus protein |
| 06/01/2010 | CA2221495C Methods and uses for apoptin |
| 05/27/2010 | WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity |
| 05/27/2010 | WO2010058846A1 4,6-diaminonicotinamide compound |
| 05/27/2010 | WO2010058824A1 Substance for regulating differentiation into mesenchymal cell, and use thereof |
| 05/27/2010 | WO2010058819A1 Peptide capable of inhibiting interaction between human tumor protein mdm2 and human tumor suppression protein p53, and use thereof |
| 05/27/2010 | WO2010058751A1 Pharmacologically acceptable salt of [1,3,4]oxadiazole compound or hydrate thereof |
| 05/27/2010 | WO2010058669A1 Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein |
| 05/27/2010 | WO2010058550A1 Therapeutic or prophylactic agent for liver diseases comprising anti-human ggt antibody |
| 05/27/2010 | WO2010058512A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives |
| 05/27/2010 | WO2010057856A1 Use of escin for treatment of type iv hypersensitivity reaction |
| 05/27/2010 | US20100132057 Genetically modified animal for use in evaluating harmfulness of test substance |
| 05/27/2010 | US20100130595 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |